A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1998

Conditions
Cytomegalovirus InfectionsHIV Infections
Interventions
DRUG

Ganciclovir

Trial Locations (19)

10032

Columbia IMPAACT CRS, New York

Incarnation Children's Ctr., New York

19134

St. Christopher's Hosp. for Children, Philadelphia

33161

Univ. of Miami Ped. Perinatal HIV/AIDS CRS, Miami

60614

Chicago Children's CRS, Chicago

70112

Tulane/LSU Maternal/Child CRS, New Orleans

90027

Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy, Los Angeles

90033

Usc La Nichd Crs, Los Angeles

90095

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles

90502

Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases, Torrance

92093

UCSD Maternal, Child, and Adolescent HIV CRS, San Diego

94609

Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab., Oakland

Unknown

Univ. of Colorado Denver NICHD CRS, Aurora

BMC, Div. of Ped Infectious Diseases, Boston

St. Joseph's Hosp. & Med. Ctr. of New Jersey, Paterson

NYU Med. Ctr., Dept. of Medicine, New York

UW School of Medicine - CHRMC, Seattle

Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS, San Juan

02115

HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000805 - A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease | Biotech Hunter | Biotech Hunter